Share this video  

VJOncology is committed to improving our service to you

GU Cancers 2020 | RADVAX: pembrolizumab plus radiotherapy

Hans Hammers, MD, PhD, The University of Texas Southwestern, Dallas, TX, discusses the RADVAX trial (NCT02303990), a stratified Phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with advanced and metastatic Cancers. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter